文献速递间质性肺疾病肺结节与肺癌

间质性肺异常与肺癌风险:国家肺癌筛查试验分析

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial.
PubMed 文献 · Chest · 2019-08-09

该研究基于国家肺癌筛查试验中接受低剂量CT的25041名参与者,评估无症状间质性肺异常是否独立增加肺癌风险。结果显示间质性肺异常患病率为20.2%,与肺癌发病率升高相关(粗发病率比1.61,95%CI 1.30-1.99;校正后1.33,95%CI 1.07-1.65),且肺癌特异性死亡率亦更高,提示其可作为独立风险因素纳入风险评分模型。

要点

  • 无症状间质性肺异常在筛查人群中常见,患病率约20.2%。
  • 间质性肺异常与肺癌发病率升高独立相关(校正IRR 1.33)。
  • 间质性肺异常者肺癌特异性死亡率亦更高,可纳入风险评分。

核心结论

  • 无症状间质性肺异常是肺癌的独立风险因素,可纳入风险评分模型。

研究设计与样本

  • 分析国家肺癌筛查试验中所有参与者,排除已有间质性肺病或现患肺癌者。
  • 主要分析纳入接受低剂量CT成像者,接受胸部X线者用于验证性分析。

主要发现

  • 低剂量CT主要分析共25041名参与者,20.2%存在间质性肺异常。
  • 间质性肺异常者肺癌发病率更高,粗发病率比1.61(95%CI 1.30-1.99)。
  • 校正分析中间质性肺异常仍与肺癌发病率升高相关,发病率比1.33(95%CI 1.07-1.65)。
  • 间质性肺异常者肺癌特异性死亡率亦更高。
  • 胸部X线验证分析获得相似结果。

关键数值与推荐

  • 间质性肺异常定义为存在网状/网结节状阴影、蜂窝状改变、纤维化或瘢痕。
  • 主要分析人群为接受低剂量CT成像的25041名参与者。

临床怎么用

  • 在肺癌筛查风险评估中可考虑纳入无症状间质性肺异常以优化风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some interstitial lung diseases are associated with lung cancer. However, it is unclear whether asymptomatic interstitial lung abnormalities convey an independent risk. OBJECTIVES: The goal of this study was to assess whether interstitial lung abnormalities are associated with an increased risk of lung cancer. METHODS: Data from all participants in the National Lung Cancer Trial were analyzed, except for subjects with preexisting interstitial lung disease or prevalent lung cancers. The primary analysis included those who underwent low-dose CT imaging; those undergoing chest radiography were included in a confirmatory analysis. Participants with evidence of reticular/reticulonodular opacities, honeycombing, fibrosis, or scarring were classified as having interstitial lung abnormalities. Lung cancer incidence and mortality in participants with and without interstitial lung abnormalities were compared by using Poisson and Cox regression, respectively. RESULTS: Of the 25,041 participants undergoing low-dose CT imaging included in the primary analysis, 20.2% had interstitial lung abnormalities. Participants with interstitial lung abnormalities had a higher incidence of lung cancer (incidence rate ratio, 1.61; 95% CI, 1.30-1.99). Interstitial lung abnormalities were associated with higher lung cancer incidence on adjusted analyses (incidence rate ratio, 1.33; 95% CI, 1.07-1.65). Lung cancer-specific mortality was also greater in participants with interstitial lung abnormalities. Similar findings were obtained in the analysis of participants undergoing chest radiography. CONCLUSIONS: Asymptomatic interstitial lung abnormalities are an independent risk factor for lung cancer that can be incorporated into risk score models.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Whittaker Brown SA, Padilla M, Mhango G, et al. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial. Chest. 2019. PMID: 31404527. doi:10.1016/j.chest.2019.06.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。